Indication
atypical
3 clinical trials
2 products
1 drug
Clinical trial
A Double-Blind Placebo-Controlled Evaluation of Effectiveness of Oral Naltrexone in Management of Adolescent Eating DisordersStatus: Terminated, Estimated PCD: 2024-05-21
Product
NaltrexoneClinical trial
Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring: Prospective Health-economic Evaluation in Patients in Remission With Atypical Hemolytic Uraemic Syndrome Requiring Long-term Treatment.Status: Active (not recruiting), Estimated PCD: 2023-12-28
Product
EculizumabClinical trial
Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents With Eating DisordersStatus: Recruiting, Estimated PCD: 2026-09-01
Drug
Varlilumab